These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

902 related articles for article (PubMed ID: 7599335)

  • 21. Drugs for treatment of peptic ulcers.
    Dajani EZ; Trotman BW
    J Assoc Acad Minor Phys; 1992; 3(3):78-88. PubMed ID: 1353999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
    Koch M; Dezi A; Ferrario F; Capurso I
    Arch Intern Med; 1996 Nov; 156(20):2321-32. PubMed ID: 8911239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of NSAID-gastropathy.
    Ardizzone S; Bianchi Porro G
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.
    Hawkey CJ; Karrasch JA; Szczepañski L; Walker DG; Barkun A; Swannell AJ; Yeomans ND
    N Engl J Med; 1998 Mar; 338(11):727-34. PubMed ID: 9494149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An etiologic approach to management of duodenal and gastric ulcers.
    Rex DK
    J Fam Pract; 1994 Jan; 38(1):60-7. PubMed ID: 8289053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antisecretory drugs and prophylaxis of secondary gastrointestinal effects associated with the consumption of non steroid anti-inflammatory drugs].
    Lanas A; Arroyo MT
    Med Clin (Barc); 2000; 114 Suppl 2():57-62. PubMed ID: 10916808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effects of prostaglandins against nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury.
    Dajani EZ; Agrawal NM
    Int J Clin Pharmacol Res; 1989; 9(6):359-69. PubMed ID: 2699464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy of prostaglandin derivatives and mucoprotective drugs in treatment and prevention for NSAIDs-induced ulcer].
    Fujikawa Y; Watanabe T; Tominaga K; Fujiwara Y; Sato H; Arakawa T
    Nihon Rinsho; 2011 Jun; 69(6):1039-43. PubMed ID: 21688624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy of NSAIDs-induced gastropathy.
    La Corte R; Caselli M; Ruina M; Bajocchi G; Alvisi V; Trotta F
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():37-41. PubMed ID: 9032582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression.
    Lad R; Armstrong D
    Can J Gastroenterol; 1999 Mar; 13(2):135-42. PubMed ID: 10203432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of NSAID-induced ulcer disease.
    Clearfield HR
    Am Fam Physician; 1992 Jan; 45(1):255-8. PubMed ID: 1728095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevention and therapy of NSAID-induced ulcers: fact versus myth].
    Fried M; Bertschinger P
    Schweiz Med Wochenschr; 1996 Sep; 126(37):1569-72. PubMed ID: 8927961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment and prevention of gastrointestinal complications caused by non-steroidal antiphlogistic agents].
    Rybár I; Kriska M; Vavrecka A; Hyrdel R; Rovenský J
    Cas Lek Cesk; 1999 Nov; 138(22):675-80. PubMed ID: 10746025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytoprotection with misoprostol: use in the treatment and prevention of ulcers.
    Ballinger A
    Dig Dis; 1994; 12(1):37-45. PubMed ID: 8200123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Healing of NSAID-induced gastric ulcers with a synthetic prostaglandin analog (enprostil).
    Sontag SJ; Schnell TG; Budiman-Mak E; Adelman K; Fleischmann R; Cohen S; Roth SH; Ipe D; Schwartz KE
    Am J Gastroenterol; 1994 Jul; 89(7):1014-20. PubMed ID: 8017358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Points that should be considered for selecting drugs for the prevention and treatment of NSAIDs-related ulcers].
    Kinoshita Y; Tamagawa Y
    Nihon Rinsho; 2011 Jun; 69(6):1044-8. PubMed ID: 21688625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of nonsteroidal anti-inflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal anti-inflammatory drug-induced damage.
    Cryer B; Feldman M
    Arch Intern Med; 1992 Jun; 152(6):1145-55. PubMed ID: 1599341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage.
    Singh G; Triadafilopoulos G
    Int J Clin Pract; 2005 Oct; 59(10):1210-7. PubMed ID: 16178990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.